Clinical Studies of TQB2930 Injection for the Treatment of Advanced Solid Tumors
Clinical trial NCT07512583 · RECRUITING
Trial details
- NCT number
- NCT07512583
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-27
- Primary completion
- 2028-03-01
- Enrollment
- 178
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.